Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Cytokine-mediated inflammation is increasingly recognized for playing a vital role in the pathophysiology of a wide range of brain disorders, including neurodegenerative, psychiatric, and neurodevelopmental problems. Pro-inflammatory cytokines such as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) cause neuroinf...
Alternative Titles
Full title
Targeting Cytokine-Mediated Inflammation in Brain Disorders: Developing New Treatment Strategies
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9dc4f70c1d6046c4969d74e887903763
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9dc4f70c1d6046c4969d74e887903763
Other Identifiers
ISSN
1424-8247
E-ISSN
1424-8247
DOI
10.3390/ph18010104
